Abstract
Frontline rescue workers during the COVID-19 pandemic faced heightened psychological risks, yet existing tools like PHQ-9 and GAD-7 lack crisis-specific relevance and brevity. This study aimed to develop and validate a simplified risk probability scale (SRPS) tailored for rapid self-assessment of depression and anxiety in frontline rescue teams. A cross-sectional survey of 273 frontline workers in Lanzhou, China, was conducted using snowball sampling. Participants completed questionnaires integrating socio-economic, occupational, and psychological metrics, analyzed via univariate, multivariate, and ROC curve analyses. Key findings revealed middle-income earners (3000–4000 CNY/month) faced elevated depression risk [OR=3.666, 95%CI (1.085-12.385), p=0.036], while work stress intolerance strongly predicted anxiety [OR=14.258, 95%CI (4.213-58.983), p<0.001]. The SRPS demonstrated moderate predictive accuracy (depression AUC=0.572, sensitivity=58.2%, specificity=53.7%; anxiety AUC=0.662, sensitivity=72.5%, specificity=64.8%)] but prioritized brevity (10 items) and contextual relevance over diagnostic precision. The tool’s integration into mobile health platforms offers real-time screening potential, enabling targeted interventions for high-risk groups. This study highlights the necessity of context-specific mental health tools in crisis settings and provides a foundation for scalable, dynamic risk assessment in future public health emergencies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study has been approved by Affiliated Hospital of Yangzhou University IRB Committee (IRB No: 2024-YKL08-002). Informed consent was signed by all participants during the SRPS study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos